Peptide drugs can target complex proteins but often lack stability in the body.
⏯️ Vahe Bandarian discusses how @SetheraTx is engineering complex peptides and translating academic discoveries into real-world applications: youtu.be/Iwtz4Ew08u8?si=Pvf6….
#PeptideTherapeutics #Biotech
Sethera Therapeutics retweeted
New article from @SetheraTx CEO, Karsten Eastman in this week's Drug Discovery News: Reimagining enzyme function for synthetic biology and drug discovery drugdiscoverynews.com/reimag…
Sethera Therapeutics retweeted
Check out our recent publication on enzymatic modification of GLP1 analogs! We think this is really exciting because it opens many unique doors for architectural changes in late-stage peptide development. pubs.acs.org/doi/10.1021/acs…
Sethera Therapeutics retweeted
Follow @SetheraTx for new #peptide-based #therapeutics designed to engage multiple targets simultaneously, paving the way for innovative treatments for cancer and other challenging diseases.
Sethera Therapeutics is revolutionizing peptide-based drug development with our cutting-edge enzymatic cross-linking technology. setheratx.com/





